Cadila Healthcare has informed about submission of a copy of press release dated November 21, 2019 titled ‘Zydus receives final approvals from the USFDA for Isosorbide Dinitrate Tablets and Desonide Cream’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.